Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
Dermatology (Basel, Switzerland)|February 22, 2000
Interferon-alpha-associated development of bullous lesions in mycosis fungoidesC Pföhler, S Ugurel, S Seiter, et al.Oncology Reports|December 15, 2000
Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanomaD O Hasselmann, G Rappl, M Rössler, et al.Cell Death and Differentiation|September 11, 2001
The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15)G Rappl, H Abken, D O Hasselmann, et al.Cancer|July 24, 2001
Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapyS Ugurel, V Rebmann, S Ferrone, et al.Annals of the New York Academy of Sciences|November 16, 2001
Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanomaG Rappl, D O Hasselmann, M Rössler, et al.Onkologie|December 14, 2004
Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanomaW Fink, C Zimpfer-Rechner, A Thoelke, et al.Journal of the American Academy of Dermatology|February 24, 2001
CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndromeG Rappl, J M Muche, H Abken, et al.Der Internist|May 29, 2020
[Immunotherapy for malignant melanoma]A Zaremba, L Zimmer, K G Griewank, et al.The Journal of Investigative Dermatology|February 13, 2001
Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alphaG Rappl, A Kapsokefalou, C Heuser, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|January 13, 2021
[Cutaneous angiosarcoma clinically presenting as Quincke's edema]M Albrecht, E Hadaschik, L Zimmer, et al.Pageof 6